^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Adrenal Cortex Carcinoma

4d
Analysis of clinical and pathological characteristics of classic adrenocortical carcinoma. (PubMed, Sci Rep)
Pathway analysis in patients with high MKI67 expression revealed an enrichment of genes associated with cell cycle regulation and p53 signaling, suggesting a potential link between high proliferative activity and these molecular pathways. In conclusion, this study provides valuable insights into the clinical and pathological profiles of ACC in the Chinese population, facilitating better diagnostic approaches.
Journal
|
MKI67 (Marker of proliferation Ki-67)
7d
Molecular profile of Cushing's syndrome. (PubMed, Vitam Horm)
These molecular insights have direct clinical implications, enabling refined disease classification, improved prognostic stratification, and the identification of actionable therapeutic targets, including EGFR, MAPK, PKA, and glucocorticoid receptor-associated pathways. Collectively, the integration of multi-omics approaches is redefining the conceptual framework of Cushing's syndrome and paving the way toward precision medicine strategies in endocrine oncology.
Journal
|
EGFR (Epidermal growth factor receptor) • BRAF (B-raf proto-oncogene) • TP53 (Tumor protein P53) • ATRX (ATRX Chromatin Remodeler) • IGF2 (Insulin-like growth factor 2) • GNAS (GNAS Complex Locus) • PRKACA (Protein Kinase CAMP-Activated Catalytic Subunit Alpha)
|
BRAF mutation
7d
Tumor stage-dependent expression of autophagy proteins in adrenocortical carcinoma. (PubMed, Front Endocrinol (Lausanne))
A punctate LC3B expression accumulation, associated with less aggressive malignant features, namely absence of metastasis, appears to result from a blockade at the late stages of autophagy. Whereas active autophagy may be associated with a more aggressive cellular phenotype in ACC, particularly by promoting migration and invasion.
Journal
|
SQSTM1 (Sequestosome 1) • ATG5 (Autophagy Related 5) • MAP1LC3B (Microtubule Associated Protein 1 Light Chain 3 Beta)
7d
SWOG S1609: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (clinicaltrials.gov)
P2, N=798, Active, not recruiting, National Cancer Institute (NCI) | Trial primary completion date: May 2027 --> May 2026
Trial primary completion date
|
CD4 (CD4 Molecule)
|
PD-L1 overexpression
|
Opdivo (nivolumab) • Yervoy (ipilimumab) • ABP 206 (nivolumab biosimilar)
12d
Adrenal neuroblastoma presenting as lameness in a six-year-old boy: a case report. (PubMed, Urol Case Rep)
Histopathological examination confirmed a differentiating NB. The postoperative course was uneventful.
Journal
|
MYCN (MYCN Proto-Oncogene BHLH Transcription Factor)
15d
OCT4 and NANOG are involved in adrenocortical tumorigenesis. (PubMed, Arch Endocrinol Metab)
Markers of pluripotency and self-renewal of embryonic stem cells are expressed until mid-pregnancy, contributing to the adult adrenal stem cell niche. They are absent postnatally but are expressed in a subset of ACT. Specifically, pS45P beta-catenin-mutated ACTs express more NANOG. Increased OCT4 expression in pACT is associated with worse prognosis, and inhibiting the Wnt/beta-catenin pathway in these cells impairs NANOG expression.
Journal
|
STAT3 (Signal Transducer And Activator Of Transcription 3) • SOX2 • POU5F1 (POU Class 5 Homeobox 1) • NANOG (Nanog Homeobox)
|
POU5F1 expression
16d
Association of gestational choriocarcinoma in a mother and Li-Fraumeni syndrome in her child: The result of a single event? (PubMed, Fam Cancer)
We present the first case of a TP53 mutation from non-carrier parents affecting both mother and child to date. We describe the pathogenic variant and the possible mechanism underlying the co-occurrence of the proband's LFS and her mother's gestational choriocarcinoma.
Journal
|
TP53 (Tumor protein P53)
|
TP53 mutation
17d
Adrenocortical Carcinoma in Peutz-Jeghers Syndrome With a Rare STK11 Pathogenic Germline Variant: A Case Report. (PubMed, Cancer Rep (Hoboken))
This is the second report of ACC associated PJS in a rare germline variant of STK11. Although rare, loss of STK11 function may lead to cancers outside expected sites in PJS cases.
Journal
|
STK11 (Serine/threonine kinase 11)
|
STK11 mutation
|
OncoGuide™ NCC Oncopanel System
|
cisplatin • doxorubicin hydrochloride • etoposide IV • Lysodren (mitotane)
18d
Pervasive chromosomal instability drives the karyotypic evolution of hypodiploid tumours. (PubMed, Genome Med)
Together, these findings provide the first pan-cancer characterization of hypodiploidy as a widespread and clinically relevant phenomenon often driven by pervasive chromosomal instability, and illustrate the remarkable ability of cancer cells to tolerate and evolve under extreme dosage imbalance.
Journal
|
TP53 (Tumor protein P53)
|
TP53 mutation
19d
Genotypic and phenotypic characteristics of germline TP53 variant carriers: experience from two cancer genetic counseling units. (PubMed, Fam Cancer)
Eight carriers (34.7%) developed second primaries after a median interval of 6 years, and four developed third primaries. Functional classification may contribute to risk stratification; however, these findings are exploratory and hypothesis-generating, and require validation in larger prospective cohorts.
Retrospective data • Journal
|
TP53 (Tumor protein P53)
19d
New trial
|
CXCR4 (Chemokine (C-X-C motif) receptor 4)
20d
Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective. (PubMed, Clin Chim Acta)
Multi-omics classification consistently identifies two distinct biologically based subtypes with therapeutic implications. We also discuss the pre-analytical, analytical, and inter-laboratory standardization requirements that must be met before each biomarker layer can be translated to the clinical chemistry laboratory and advocate a multi-omic implementation strategy for ACC diagnosis, prognosis, and recurrence detection.
Review • Journal
|
KPNA2 (Karyopherin Subunit Alpha 2)